Triple agonists like retatrutide are emerging as next-generation options with potentially different side effect profiles
Its worth considering these changes might occur for other reasons too, such as hormonal changes, other medications, or even genetics, he shared
PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega- O -acylceramide synthesis and skin permeability barrier
Nevertheless, translating these experimental technologies into safe, effective, and commercially viable products requires extensive clinical trials to establish pharmacokinetics, bioavailability, efficacy, and safety profiles
Lipid profiles improve, particularly through lower LDL and higher HDL levels
A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2032